Siddhi

Circuit Monitoring Market to Grow at Robust CAGR owing to Increasing Implementation of Automation in Industries
The circuit monitoring market includes several devices used for monitoring electric circuits to ensure smooth functioning and safe operation. Some commonly used circuit monitoring devices include modular metering systems, revenue metering systems, data loggers, power quality meters, energy analyzers and sensing meters. These devices offer advantages like remote monitoring capabilities, accurate measurement of parameters like voltage, current and power factor and detection of circuit faults. With growing automation and integration of advanced technologies across industries, there has been a significant rise in the demand for circuit monitoring systems to prevent equipment damage, downtime and ensure personnel safety. The circuit monitoring market is estimated to be valued at USD 694.29 Mn in 2024 and is expected to reach USD 959.15 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.72% from 2024 to 2031.Key TakeawaysKey players operating in the circuit monitoring market are Schneider Electric, ABB, Siemens, Honeywell, Emerson, and Eaton. Growing demand from industries like automotive, manufacturing, oil & gas, mining, data centers and commercial buildings is driving the need for Circuit Monitoring Market. Utilities sector is also contributing significantly to revenue growth.Advancements in sensor technologies, emergence of IoT based monitoring devices and adoption of cloud computing are allowing circuit monitoring systems to offer remote access, predictive maintenance capabilities and energy management solutions.Market TrendsIntegration with AI and analytics- Major players are focusing on integrating circuit monitoring devices with advanced analytics and artificial intelligence capabilities. This allows prediction of faults, automated responses and optimization of energy usage.Adoption of wireless monitoring systems- Wireless circuit monitoring systems that can be installed without cabling are gaining popularity due to easy deployment. Growth in number of wireless sensors and network infrastructure is aiding their adoption.Market Opportunities Emergence of microgrid systems- Increasing focus on localized renewable energy sources is propelling demand for monitoring and control solutions for microgrid installations across commercial and industrial facilities.Smart city infrastructure projects- Implementation of smart street lighting, traffic management, utility systems etc. under smart city missions worldwide presents significant growth opportunities.Impact of COVID-19 on Circuit Monitoring Market GrowthThe ongoing coronavirus pandemic has significantly impacted the growth of the circuit monitoring market. The rapid spread of the virus led to nationwide lockdowns across major economies, which disrupted supply chains and halted economic activities. This majorly affected the demand for circuit monitoring equipment in 2020. Various industries like manufacturing, construction, oil & gas, and others witnessed a sharp decline in their operations during the lockdown period. With restrictions on travel and movement of goods, scheduled maintenance and upgradation of circuit systems were postponed. This caused a steep plunge in the sales of circuit monitoring devices. However, as lockdowns are being gradually lifted, the market is expected to recover in 2021. With resumption of industrial activities, the need for circuit monitoring will rise to ensure safety, reliability, and efficiency of power supply systems. Various preventive measures are also being undertaken by industries to manage electrical circuits during the pandemic. Advance monitoring equipment provides real-time data analysis and alerts on critical circuit parameters from remote locations. This helps in contactless condition monitoring supporting social distancing norms. Moreover, increased investments in renewable energy generation are boosting deployments of intelligent monitoring solutions. In terms of regions, North America holds the major share of the circuit monitoring market in value terms, owing to high industrialization and early adoption of advanced technologies. The region is home to many pioneering circuit equipment manufacturers with strong distribution networks. Asia Pacific is recognized as the fastest growing regional market and is expected to witness the highest CAGR during the forecast period. Considerable government investments to modernize power infrastructures combined with growing manufacturing industries are fueling the demand. Countries like China, India are installing smart grid networks that employ cutting-edge monitoring systems for reliability assurance.The geographical area where the value of circuit monitoring equipment installed is highly concentrated is North America, primarily United States. Being one of the most industrialized economies, USA accounts for over 30% of the global market value. It has a strong manufacturing sector along with critical industries like oil & gas, chemicals, metals & mining which heavily rely on robust circuit management systems. However, in terms of fastest growth potential, Asia Pacific region especially China and India provide lucrative opportunities. These nations are undergoing rapid industrialization with increasing focus on 'Make in India' and 'Smart Cities' initiatives that will augment circuit system augmentation and digitalization needs.
Siddhi
Chronic Idiopathic Urticaria Treatment Market to Thrive on Rising Awareness About Chronic Hives
Chronic Idiopathic Urticaria (CIU), commonly known as chronic hives, is a type of chronic urticaria that appears for more than six weeks. It is caused by mast cell and basophil degranulation and the release of vasoactive mediators, resulting in the formation of wheals and flare-like lesions on the skin. CIU is treated with antihistamines such as Hydroxyzine. With rising awareness about chronic hives and its available treatment options, people are increasingly opting for doctor consultation and treatment of the condition, thereby contributing to the growth of the chronic idiopathic urticaria treatment market. The Chronic Idiopathic Urticaria (CIU) treatment market is estimated to be valued at USD 15.12 Bn in 2024 and is expected to reach USD 25.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8% from 2024 to 2031.Key Takeaways- Key players operating in the CIU treatment market are Pfizer, Johnson & Johnson Services, Teva Pharmaceutical Industries, Sanofi, Allergan, Bayer, AbbVie, and Novartis.- Increasing prevalence of chronic hives owing to rising environmental pollution and changing lifestyles is driving the Chronic Idiopathic Urticaria Treatment Market growth. According to estimates, CIU affects nearly 0.5-1% of the global population. - Technological advancements have led to the development of novel therapeutic agents for CIU treatment. Drugs like Xolair (omalizumab) and Cimerli (rabeprazole) are more effective options with fewer side effects.Market Trends- Growing preference for biologics and targeted therapies: Biologics like omalizumab and targeted therapies inhibiting immunoglobulin E have shown promising results and are replacing the first-line antihistamines. - Shift towards online pharmacies: Online pharmacies provide convenient access to CIU medications at lower costs. This trend is expected to gain traction over the forecast period.Market Opportunities- Scope for combinations and fixed-dose combinations of drugs: Combination therapies provide synergistic effects with reduced dosage and side effects.- Potential in untapped Asian and Latin American markets: Developing regions in Asia Pacific and Latin America with large patient pools present significant growth opportunities.The COVID-19 pandemic has significantly impacted the growth of the Chronic Idiopathic Urticaria (CIU) Treatment market. During the initial stages of the pandemic, both patients and healthcare providers were advised to limit non-essential visits and procedures to help contain the spread of the virus. This resulted in postponement of chronic disease management, including follow-up consultations and treatment for CIU patients. Manufacturing and supply chain disruptions also led to shortages and delayed availability of certain antihistamines and immunosuppressants used for CIU treatment. However, as the pandemic progressed and safety protocols were established, healthcare systems were able to gradually resume chronic disease management. Telemedicine also played a key role in maintaining consultations and treatment adherence for CIU patients during lockdowns. With growing awareness about managing chronic conditions even during the pandemic, demand is expected to rise in the post-COVID period. Nonetheless, occasional flare-ups of infections may lead to temporary declines depending on the severity of subsequent waves.The market will need to focus on ensuring uninterrupted supply of essential medications, educating patients about treatment continuity, and further enhancing telemedicine capabilities. Collaboration between pharmaceutical companies and healthcare providers will be important to prepare for future crises while meeting needs of CIU patients.In terms of geography, North America currently holds the largest share of the CIU treatment market in terms of value, due to high per capita healthcare spending and uptake of expensive biologics in the region. Within North America, the United States accounts for the major market share. The Asia Pacific region is expected to exhibit the fastest growth over the forecast period for the CIU treatment market. This can be attributed to growing healthcare infrastructure, rising medical tourism, and increasing access to newer treatment options in emerging Asia Pacific countries like China, India and South Korea.
Siddhi
Chondrosarcoma Market Poised to Grow Due to Rising Cancer Cases
The chondrosarcoma market is gaining traction owing to increasing incidences of bone cancer cases. Chondrosarcoma is a type of bone cancer that starts in the cartilage cells or soft connective tissues. Treatment of chondrosarcoma relies on the stage and grade of the cancer cells and includes chemotherapy, radiation therapy, and surgery.
Siddhi
Cerebrotendinous Xanthomatosis Market to Grow Owing to Increasing Research Activities
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid storage disease caused due to a deficiency of sterol 27-hydroxylase leading to an accumulation of cholestanol and other cholesterol precursors in tissues. CTX is characterized by tendon xanthomas, early-onset cataracts, neurological disorders like cerebral degenerative diseases, diarrhea, and others. Treatment involves supplementation with chenodeoxycholic acid for decreasing the toxic effects of excess cholestanol and control of neurological problems with anti-seizure and other medications.The cerebrotendinous xanthomatosis market is estimated to be valued at USD 167.3 Mn in 2024 and is expected to reach USD 359.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.
Siddhi
Cervical Dystonia Market will grow at highest pace owing to rising awareness and product development
The cervical dystonia treatment market comprises botulinum toxin injections and other therapies including oral medications and surgical treatments. Botulinum toxin is the first line of treatment which works by blocking chemical signals to muscles thereby relaxing the muscles of the neck. Rising awareness about the availability of effective treatments and efforts towards reducing stigma are driving more patients to seek treatment for cervical dystonia.
Siddhi
Cardiac Restoration Systems Market in North America will grow at highest pace owing to rising cardiac issues
The cardiac restoration systems market deals with cardiac support devices like ventricular assistance devices, coronary sinus reducers, annuloplasty rings etc. These systems play an important role in heart failure treatment by enhancing the functioning of the heart chambers. The market is primarily driven by rising cardiovascular diseases and growing geriatric population who are more prone to such ailments. Cardiac restoration systems offer minimally invasive treatment options and help improve the quality of life of patients suffering from heart failure.
Siddhi
Cardiac Amyloidosis Market will grow at highest pace owing to increasing research investments
The cardiac amyloidosis market is primarily driven by increasing prevalence of cardiac amyloidosis and growing research investments. Cardiac amyloidosis is a rare disease caused by accumulation of abnormal amyloid protein in the heart muscle. The buildup of amyloid protein in the heart weakens and stiffens the heart which leads to heart failure over time if left untreated. Currently, there are limited treatment options available for cardiac amyloidosis such as chemotherapy, stem cell transplant, drugs to reduce amyloid production and certain lifestyle changes.
Siddhi
The Cannabis Use Disorder Market will grow at highest pace owing to increasing legalization of cannabis
The cannabis use disorder market consists of products and therapies for cannabis use disorder. Cannabis use disorder, previously known as cannabis abuse or dependence, is characterized as a pattern of prolonged excessive cannabis use despite harm to physical or mental health and quality of life. Common symptoms include withdrawal symptoms when not using cannabis, increasing tolerance to cannabis, failed attempts to quit, spending excessive time obtaining and using cannabis, giving up important social activities due to cannabis use, and continued use despite physical or psychological problems caused by cannabis. As per the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), symptoms include craving, spending inordinate amounts of time obtaining and using cannabis, continued use despite physical or psychological problems, tolerance to effects, withdrawal symptoms when not using, cannabis use resulting in failure to fulfill major role obligations at work, school, or home. The cannabis use disorder market is estimated to be valued at USD 1.64 Bn in 2024 and is expected to reach USD 3.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.33% from 2024 to 2031.Key Takeaways Key players operating in the cannabis use disorder market are Indivior, Pfizer, Alkermes, Novartis, and Mylan. These key players are focusing on developing novel therapies for cannabis use disorder.Increasing legalization and recreational use of cannabis is a major factor driving the growth of Cannabis Use Disorder Market. Several countries and states have legalized medical and recreational use of cannabis in recent years. This has led to a rise in cases of cannabis use disorder. Technological advancements in developing novel treatment modalities for cannabis use disorder is also boosting the market growth. Companies are developing drugs to treat withdrawal symptoms, reduce cravings, block euphoric effects, and reduce relapse rates. Digital therapeutics and cognitive behavioral therapies are also gaining traction.Market Trends- Increase in research funding for developing new cannabis use disorder drugs by government organizations and private bodies. National Institute on Drug Abuse (NIDA) is actively funding research projects.- Combination therapies that involve pharmacological and non-pharmacological approaches are being explored. Combining medications with psychotherapy, contingency management approaches, digital therapies are under investigation. Market Opportunities- Developing drugs that can selectively target symptoms like craving and withdrawal symptoms with minimal side effects offers significant opportunities. - Developing digital therapeutics and mobile health apps for monitoring symptoms, managing triggers, providing CBT could be an effective low-cost approach and presents major opportunities.Impact of COVID-19 on Cannabis Use Disorder Market growthThe COVID-19 pandemic had a significant impact on the Cannabis Use Disorder market. During the initial months of the pandemic in 2020, many countries imposed strict lockdowns and restrictions on movements to curb the spread of the virus. This disrupted regular healthcare services and affected the access to treatment and diagnosis of patients suffering from Cannabis Use Disorder. Hospitals had to shift focus towards managing COVID-19 cases, leading to the postponement of non-emergency procedures and outpatient appointments related to Cannabis Use Disorder. The social isolation caused by lockdowns and restricted social interactions also negatively impacted the mental health of many individuals. This increased the risk of substance abuse relapse or escalation of Cannabis Use Disorder among patients. However, as healthcare systems adapted to the new normal, facilities resumed Cannabis Use Disorder treatment services with necessary safety protocols. Telehealth and digital solutions helped bridge the gap and ensured continuity of care. In the post-COVID scenario, awareness about mental health issues has increased. This is prompting more individuals to seek help for conditions like Cannabis Use Disorder. Treatment providers are also enhancing their digital capabilities to facilitate remote monitoring and support.Geographical concentration of Cannabis Use Disorder Market value North America accounts for the largest share of the global Cannabis Use Disorder market in terms of value. This is mainly due to the early legalization of medical cannabis in countries like the US and Canada. Widespread social acceptance of cannabis use and growing awareness about associated disorders have also boosted the North America Cannabis Use Disorder market size. Moreover, the presence of leading treatment providers and favorable reimbursement structures help patients afford care easily in this region.Fastest growing region for Cannabis Use Disorder MarketAsia Pacific region is poised to witness the fastest growth in the Cannabis Use Disorder market during the forecast period. Factors like rising affluence, increasing health spending, growing patient volumes and changing social attitudes are driving the APAC market. Countries like India, China, Japan, Australia and South Korea are emerging as new hotspots. While regulatory acceptance of cannabis is still evolving in Asia, rising economic capabilities are allowing more individuals to seek professional help. This provides a strong growth foundation for Cannabis Use Disorder treatment providers targeting the Asian markets.
Siddhi
The Biliary Tumor Market will grow at highest pace owing to continuous innovations in medical technologies.
The biliary tumor market comprises products that are used to diagnose and treat biliary tumors, also known as bile duct tumors. Biliary tumors develop in the bile ducts, which are thin tubes that carry bile from the liver to the small intestine. Some key products in this market include magnetic resonance imaging (MRI) systems, ultrasound systems, endoscopic retrograde cholangiopancreatography (ERCP) devices, positron emission tomography (PET) scans, biopsy needles and systems, and biliary drainage and obstruction devices. MRI and ultrasound systems help detect and stage biliary tumors efficiently. ERCP devices assist in unblocking the bile duct during jaundice. PET scans provide information about cancer spread. Biopsy is important for tumor diagnosis. Drainage devices help relieve jaundice by draining blocked bile.
Siddhi
Buerger's Disease Market will grow at highest pace owing to increasing research & development activities
Buerger's disease, also known as thromboangiitis obliterans, is a non-atherosclerotic, segmental inflammatory disease that most commonly affects small and medium-sized arteries and veins of the lower extremities. The exact cause of Buerger's disease is unknown, but it is strongly linked to tobacco use and smoking. The disease results in inflammation and clotting within the blood vessels, which causes them to become blocked or damaged. Common symptoms include pain, numbness, weakness, and color changes in the legs and feet due to poor blood flow. Treatment involves tobacco cessation methods, blood-thinning medications, prostanoids, and surgical therapies such as angioplasty, bypass surgery or amputation as a last resort.
Siddhi
Rising Health And Wellness Trend Among Consumers fueling The Botanicals Market Growth
The botanicals market involves cultivation, extraction, and formulation of botanical ingredients derived from various plants and plant parts, including flowers, bark, leaves, and roots. Key botanical extracts comprise echinacea, ginger, turmeric, garlic, ginseng, skullcap, feverfew, and chamomile, which are used extensively in dietary supplements, functional foods & beverages, personal care products and other healthcare applications due to their medicinal properties and health benefits.
Siddhi
Bone Metastasis in Solid Tumors Market Will Grow at Highest Pace Owing to Increasing Incidence of Solid Tumors
The bone metastasis in solid tumors market involves key products such as bisphosphonates, denosumab, chemotherapy, targeted therapy, and hormonal therapy which are used for the treatment of bone metastasis from solid tumors such as breast cancer, lung cancer, thyroid cancer, kidney cancer, and prostate cancer. Bone metastasis occurs when cancer cells from primary solid tumors like breast cancer, lung cancer, or prostate cancer spread to the bones and start growing. The bone metastasis in solid tumors market is witnessing considerable demand for products which can offer long term control of cancer progression and provide palliative care for cancer pain and skeletal related events associated with bone metastasis. The bone metastasis in solid tumors market is estimated to be valued at USD 3.8 billion in 2024 and is expected to reach USD 6.73 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.Key TakeawaysKey players operating in the bone metastasis in solid tumors are Amgen Inc.,Novartis AG,Pfizer Inc.,Bayer AG,Johnson & Johnson Services, Inc. Amgen Inc dominates the market with drugs like Xgeva and Kyprolis indicated for treatment of bone metastasis. Secondly, growing incidence of solid cancers that often spread to the bone such as breast cancer, lung cancer and prostate cancer is driving the demand for Bone Metastasis in Solid Tumors Market. According to American Cancer Society estimates, the number of new cases of breast cancer diagnosed each year is expected to reach 1.7 million by 2030 globally. Thirdly, increased research and development in advanced targeted therapies segment is likely to bring more efficacious and affordable treatment options for patients with bone metastasis in future. Ongoing clinical trials are evaluating Bisphosphonates in combination with PARP inhibitors and immunotherapy for better management of bone metastasis.Market TrendsOne, bone targeting agents segment dominates the market currently, however targeted therapy and hormonal therapy segments are expected to witness faster growth during the forecast period. This is attributed to their advantages over conventional drugs in terms of improved efficacy and tolerability. Two, rising penetration of advanced molecular diagnostic tests for early and accurate detection of bone metastasis is facilitating timely intervention and management of the condition, subsequently improving clinical outcomes.Market OpportunitiesGeographic expansion into emerging markets of Asia Pacific and Latin America presents lucrative opportunities for leading players. This is attributed to improving accessibility to cancer care and rising disposable incomes in these regions.Growing need for affordable biosimilars provides opportunity for pharmaceutical companies to offer cost-effective treatment options especially in price-sensitive developing markets where cancer burden is rising rapidly.Impact of COVID-19 on Bone Metastasis in Solid Tumors Market GrowthThe COVID-19 pandemic has impacted the growth of the bone metastasis in solid tumors market. During the peak of the pandemic in 2020-2021, the market witnessed a decline as patients avoided visiting hospitals and healthcare facilities due to lockdowns and fear of infection. This led to postponement of cancer diagnosis and treatment procedures. However, with the lifting of restrictions and resumption of healthcare services, the market is regaining lost growth momentum. Various factors are likely to influence the post-COVID growth trajectory. Demand for effective drugs and targeted therapies is rising as patients seek long-term care during the pandemic. Telehealth and remote monitoring solutions are enabling continuity of care while reducing risks. Governments are supporting healthcare digitization and ensuring uninterrupted services. Pharmaceutical firms are investing in R&D to develop advanced drugs. Furthermore, rising cancer incidence due to sedentary lifestyle and stress during lockdowns will drive the need for bone metastasis treatment over the coming years.Geographical Regions with High Bone Metastasis in Solid Tumors Market ValueNorth America currently dominates the global market in terms of value, owing to the development of advanced diagnostic tools and targeted therapies. Availability of favorable reimbursement policies and well-established healthcare infrastructure also contribute to the high market value. Meanwhile, Asia Pacific is emerging as the fastest growing regional market due to the large patient population and rising disposable incomes. China, Japan and India are expected to offer lucrative opportunities with growing acceptance of precision medicines. Governments are increasing healthcare expenditures to boost cancer care services. The market is also witnessing steady expansion in Latin America and Middle Eastern countries.Fastest Growing Region - Asia Pacific The Asia Pacific region holds significant growth potential for the bone metastasis in solid tumors market. Factors such as rapidly developing economy, growing healthcare spending, rising public awareness about cancer, and increasing adoption of advanced treatments will drive the market. Furthermore, robust penetration of key global market players in countries like China, India, Japan, and South Korea is expanding access to high-quality and affordable therapies. Growing collaborations between pharmaceutical firms and regional healthcare providers are also raising diagnostic rates. Initiatives by governments to strengthen healthcare infrastructure and reduce out-of-pocket spending will further augment the market expansion during the forecast period.
Siddhi
Rising Need for Effective Treatment Options Will Drive the Binge Eating Disorder Therapeutic Market
The binge eating disorder therapeutic market comprises medicines and therapies for controlling and treating binge eating disorder symptoms. Binge eating disorder is a serious eating disorder characterized by frequent episodes of uncontrolled eating or consuming unusually large amounts of food in a short period. People with this condition feel unable to stop eating or control how much they are eating during a binge episode. Some key features of binge eating disorder include eating much more rapidly than normal, eating until feeling uncomfortably full, eating large amounts of food when not feeling physically hungry, eating alone due to feeling embarrassed by how much one is eating, and feeling disgusted with oneself, depressed, or very guilty afterwards. The Global Binge Eating Disorder Therapeutic Market is estimated to be valued at USD 2.5 bn in 2024 and is expected to reach USD 3.4 bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Siddhi
Biliary Tract Cancers Market to grow at highest pace owing to rising prevalence of bile duct cancers
The biliary tract cancers market covers diagnosis and treatment of bile duct and gallbladder cancers. The market consists of various diagnostic tests such as blood tests, CT scans, endoscopic ultrasound, and MRI imaging to detect biliary tract cancers. The treatment landscape includes chemotherapy, radiation therapy, surgery, and targeted therapy. Biliary tract cancers are cancers that form in the bile ducts (tubes that carry bile from the liver to the small intestine) or gallbladder. Early symptoms include jaundice, abdominal pain, weight loss, and itchy skin. If detected early, biliary tract cancers can be treated through surgery. However, some patients require additional chemotherapy or radiation therapy based on the stage of cancer. The biliary tract cancers (BTCs) market is estimated to be valued at USD 0.822 billion in 2024 and is expected to reach USD 1.196 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.Key TakeawaysKey players operating in the biliary tract cancers market are F. Hoffmann-La Roche Ltd, Johnson & Johnson, Sanofi, Bayer AG, and Bristol-Myers Squibb Company. The growing prevalence of bile duct cancers and gallbladder cancers is driving the for Biliary Tract Cancers Market growth. According to the statistics, about 8,000 new cases of bile duct cancer are diagnosed in the United States every year. The risk factors such as primary sclerosing cholangitis and congenital abnormalities of the bile duct increase the risk of developing biliary tract cancers.Technological advancements are expected to boost the biliary tract cancers market during the forecast period. Companies are investing in research & development of novel diagnostic technologies such as liquid biopsy for early detection. There is also a focus on developing targeted therapies and immunotherapies to improve clinical outcomes of advanced biliary tract cancer patients.Market TrendsIncreased adoption of biomarker testing - Biomarker testing helps identify patients that are most likely to benefit from targeted therapies. Biomarker testing for FGFR2 fusions and IDH1 mutations is gaining traction in the biliary tract cancers market. Rising research into immunotherapies - Checkpoint inhibitors targeting PD-1, PD-L1, and CTLA-4 are being evaluated in clinical trials for treating advanced biliary tract cancers with promising results. This is expected to drive the use of immunotherapies in the coming years.Market OpportunitiesGrowing prevalence in Asia Pacific and Latin America - Countries like China, India, Brazil are witnessing rising bile duct and gallbladder cancer incidence rates attributed to lifestyle changes and risk factors like liver flukes. This provides opportunities for market players.Novel targeted therapies and drug combinations - Ongoing research efforts aim to develop targeted drugs with higher response rates either as monotherapy or in combination with existing treatments. Successful new drug approvals will further fuel the market growth.IMPACT OF COVID-19 ON BILIARY TRACT CANCERS (BTCs) MARKETThe outbreak of COVID-19 pandemic has negatively impacted the growth of Biliary Tract Cancers (BTCs) market globally. The mandatory lockdowns and social distancing measures imposed by various governments across the world led to temporary closure of oncology facilities and deferment of cancer diagnosis and treatments. This adversely affected the demand for BTC drugs, imaging tests and radiotherapies utilized in the management of BTCs. The restrictions on travel and transportation further limited the access to specialty healthcare centers for BTC patients. However, with relaxation in lockdowns and emergence of telehealth solutions, cancer care delivery is gradually resuming post lockdowns. The medical community realized the importance of continuing cancer care services using digital mediums. Numerous virtual consultations, remote patient monitoring systems and home delivery options for BTC drugs were implemented. Tele-oncology is expected to play a bigger role in facilitating uninterrupted care for BTC patients amid future pandemic waves. The demand for oral cancer drugs is also anticipated to increase as they allow self-administration and avoid hospital visits. North America currently accounts for the major share of BTC market in terms of value, owing to high prevalence of biliary tract diseases, rising geriatric population and established healthcare infrastructure for cancer management. Europe is also one of the prominent regions due to growing awareness initiatives and availability of advanced treatment alternatives for BTCs. Asia Pacific is poised to emerge as the fastest growing regional market for BTCs. Factors such as increasing healthcare spending, improving access to surgical and radiotherapy facilities, and rising affordability of cancer medications are likely to propel the BTC market growth across emerging nations of China, India and South Korea over next few years.
Siddhi
Bathroom Vanities Market expected to grow at highest pace owing to growing housing construction trends
The bathroom vanities market refers to stylish storage furniture that is installed below the sink, countertops and mirror in a bathroom. Bathroom vanities provide storage space for toiletries, cleaning supplies and accessories through the inclusion of cabinets with shelves and drawers, soft-closing drawers and frosted or smoked glass cabinet doors. Material choices in vanities include wood, ceramic/porcelain, laminate, glass & stone. Bathroom vanities provide adequate storage space for bathroom essentials and cosmetics while complementing the overall décor style of the bathroom.
Siddhi
The Rise of NAMPT Inhibitors Market will lead to Advancements in Cancer Therapeutics
NAMPT inhibitors have emerged as promising next-generation cancer drugs due to their role in regulating cellular metabolism. By targeting NAMPT, these novel agents can effectively starve cancer cells of energy and halt tumor growth.
Siddhi
Mydriasis Treatment Market will grow at highest pace owing to expanding geriatric population
The Mydriasis treatment market involves medications and devices used for the management of pupil dilation or mydriasis. Mydriasis refers to abnormal dilation of the pupil, usually caused by drugs like tropicamide, phenylephrine, and atropine which are used in eye examinations to dilate the pupils. Some key medications used in mydriasis treatment include pilocarpine drops which constricts the pupils and tropicamide drops which dilates the pupils. The global demand for mydriasis treatment has increased significantly over the years owing to the rising prevalence of eye diseases like glaucoma, diabetic retinopathy, and age-related macular degeneration worldwide. Furthermore, increasing geriatric population who are more susceptible to age-related eye disorders is also fueling market growth.The mydriasis treatment market is estimated to be valued at USD 633.3 Mn in 2024 and is expected to reach USD 878 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.
Siddhi
Modular Data Center Market Growth is poised to grow at highest pace owing to its lower cost of development
Modular Data Centers are self-contained, prefabricated platforms consist stackable modules and secure enclosure, along with integrated power, cooling, security and racks for housing servers, storage and networking equipment. Modular Data Centers deploy quickly with reduced downtime and risk as fully integrated modules deliver full IT capability faster and easier than traditional Developments. As these facilities are portable, scalable in nature, and optimal for temporary, disaster recovery or expansion needs, Modular Data Center Market has opened-up opportunities in high-growth markets worldwide to support digital transformation. The increasing energy efficiency and low power consumption of modular data centers have also fueled their adoption to reduce carbon footprint.
Siddhi
Medullary Thyroid Cancer Drugs Market will grow at highest pace owing to increasing product launches
Medullary thyroid cancer (MTC) is a rare form of thyroid cancer that develops from parafollicular C cells of the thyroid gland. Several drugs are available for treatment of medullary thyroid cancer including Tyrosine Kinase Inhibitors (TKI), Radionuclides/Radioisotope Therapy and Targeted Drug Therapy. Development of novel targeted therapies have increased treatment options for patients with advanced or refractory MTC.
Siddhi
Machining Market will grow at highest pace owing to demand from automotive industry
Machining is a form of subtractive metalworking where a cutting tool such as a drill or a lathe tool removes material from a workpiece to create machined parts and components. This includes drilling, boring, milling, turning, and other cutting processes where a piece of raw material is converted into a desired final shape and size. Machining finds applications in various industries including automotive, aerospace, construction, electrical & electronics and others. Key process in machining includes turning processes where a workpiece is rotated to cut off excess material, milling processes where a rotating cutter removes material along various axes and drilling processes that cuts holes into materials.
Siddhi

Siddhi

0 Followers

2 Following

Circuit Monitoring Market to Grow at Robust CAGR owing to Increasing Implementation of Automation in Industries

Siddhi

Chronic Idiopathic Urticaria Treatment Market to Thrive on Rising Awareness About Chronic Hives

Siddhi

Chondrosarcoma Market Poised to Grow Due to Rising Cancer Cases

Siddhi

Cerebrotendinous Xanthomatosis Market to Grow Owing to Increasing Research Activities

Siddhi

Cervical Dystonia Market will grow at highest pace owing to rising awareness and product development

Siddhi

Cardiac Restoration Systems Market in North America will grow at highest pace owing to rising cardiac issues

Siddhi

Cardiac Amyloidosis Market will grow at highest pace owing to increasing research investments

Siddhi

The Cannabis Use Disorder Market will grow at highest pace owing to increasing legalization of cannabis

Siddhi

The Biliary Tumor Market will grow at highest pace owing to continuous innovations in medical technologies.

Siddhi

Buerger's Disease Market will grow at highest pace owing to increasing research & development activities

Siddhi

Rising Health And Wellness Trend Among Consumers fueling The Botanicals Market Growth

Siddhi

Bone Metastasis in Solid Tumors Market Will Grow at Highest Pace Owing to Increasing Incidence of Solid Tumors

Siddhi

Rising Need for Effective Treatment Options Will Drive the Binge Eating Disorder Therapeutic Market

Siddhi

Biliary Tract Cancers Market to grow at highest pace owing to rising prevalence of bile duct cancers

Siddhi

Bathroom Vanities Market expected to grow at highest pace owing to growing housing construction trends

Siddhi

The Rise of NAMPT Inhibitors Market will lead to Advancements in Cancer Therapeutics

Siddhi

Mydriasis Treatment Market will grow at highest pace owing to expanding geriatric population

Siddhi

Modular Data Center Market Growth is poised to grow at highest pace owing to its lower cost of development

Siddhi

Medullary Thyroid Cancer Drugs Market will grow at highest pace owing to increasing product launches

Siddhi

Machining Market will grow at highest pace owing to demand from automotive industry

Siddhi